Casein kinase 1α-dependent feedback loop controls autophagy in RAS-driven cancers.

PubWeight™: 0.87‹?›

🔗 View Article (PMC 4396475)

Published in J Clin Invest on March 23, 2015

Authors

Jit Kong Cheong, Fuquan Zhang, Pei Jou Chua, Boon Huat Bay, Andrew Thorburn, David M Virshup

Articles cited by this

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv Enzyme Regul (1984) 35.22

Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell (1999) 32.32

Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy (2012) 20.08

Creation of human tumour cells with defined genetic elements. Nature (1999) 16.47

Targeting RAS signalling pathways in cancer therapy. Nat Rev Cancer (2003) 15.17

Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J Biol Chem (1998) 13.93

A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature (1995) 11.89

Autophagy: renovation of cells and tissues. Cell (2011) 11.59

Control of beta-catenin phosphorylation/degradation by a dual-kinase mechanism. Cell (2002) 10.34

FoxO3 controls autophagy in skeletal muscle in vivo. Cell Metab (2007) 8.90

FoxO3 coordinately activates protein degradation by the autophagic/lysosomal and proteasomal pathways in atrophying muscle cells. Cell Metab (2007) 8.05

Determination of subcutaneous tumor size in athymic (nude) mice. Cancer Chemother Pharmacol (1989) 7.47

Activated Ras requires autophagy to maintain oxidative metabolism and tumorigenesis. Genes Dev (2011) 7.43

Global cancer transitions according to the Human Development Index (2008-2030): a population-based study. Lancet Oncol (2012) 6.37

CDK8 is a colorectal cancer oncogene that regulates beta-catenin activity. Nature (2008) 6.24

Pancreatic cancers require autophagy for tumor growth. Genes Dev (2011) 6.17

Disruption of p53 in human cancer cells alters the responses to therapeutic agents. J Clin Invest (1999) 6.13

Post-translational modifications regulate the ticking of the circadian clock. Nat Rev Mol Cell Biol (2007) 5.24

Casein kinase 1 gamma couples Wnt receptor activation to cytoplasmic signal transduction. Nature (2005) 4.88

Altered growth of human colon cancer cell lines disrupted at activated Ki-ras. Science (1993) 4.76

Analysis of apoptosis by propidium iodide staining and flow cytometry. Nat Protoc (2006) 4.43

Autophagy facilitates glycolysis during Ras-mediated oncogenic transformation. Mol Biol Cell (2010) 3.63

The casein kinase 1 family: participation in multiple cellular processes in eukaryotes. Cell Signal (2005) 3.50

Oncogenic Ras-induced expression of Noxa and Beclin-1 promotes autophagic cell death and limits clonogenic survival. Mol Cell (2011) 3.37

Autophagy suppresses progression of K-ras-induced lung tumors to oncocytomas and maintains lipid homeostasis. Genes Dev (2013) 2.90

Phosphate groups as substrate determinants for casein kinase I action. J Biol Chem (1990) 2.83

Cytosolic FoxO1 is essential for the induction of autophagy and tumour suppressor activity. Nat Cell Biol (2010) 2.78

Assessment of the Alamar Blue assay for cellular growth and viability in vitro. J Immunol Methods (1997) 2.78

Small-molecule inhibition of Wnt signaling through activation of casein kinase 1α. Nat Chem Biol (2010) 2.71

Anti-oncogenic role of the endoplasmic reticulum differentially activated by mutations in the MAPK pathway. Nat Cell Biol (2006) 2.58

Deacetylation of FoxO by Sirt1 Plays an Essential Role in Mediating Starvation-Induced Autophagy in Cardiac Myocytes. Circ Res (2010) 2.57

Autophagy is required for glucose homeostasis and lung tumor maintenance. Cancer Discov (2014) 2.44

FoxO transcription factors promote autophagy in cardiomyocytes. J Biol Chem (2009) 2.40

CKI, there's more than one: casein kinase I family members in Wnt and Hedgehog signaling. Genes Dev (2006) 2.39

The tumor-suppressive functions of the human INK4A locus. Cancer Cell (2003) 2.31

D4476, a cell-permeant inhibitor of CK1, suppresses the site-specific phosphorylation and nuclear exclusion of FOXO1a. EMBO Rep (2004) 2.31

RNA helicase DDX3 is a regulatory subunit of casein kinase 1 in Wnt-β-catenin signaling. Science (2013) 2.27

The return of the nucleus: transcriptional and epigenetic control of autophagy. Nat Rev Mol Cell Biol (2013) 2.03

The role of ATF4 stabilization and autophagy in resistance of breast cancer cells treated with Bortezomib. Cancer Res (2009) 2.03

Inhibition of the phosphatidylinositol 3'-kinase-AKT pathway induces apoptosis in pancreatic carcinoma cells in vitro and in vivo. Mol Cancer Ther (2002) 2.03

Combined MTOR and autophagy inhibition: phase I trial of hydroxychloroquine and temsirolimus in patients with advanced solid tumors and melanoma. Autophagy (2014) 1.98

Identification of a new family of protein phosphatase 2A regulatory subunits. J Biol Chem (1995) 1.96

Hepatic autophagy is suppressed in the presence of insulin resistance and hyperinsulinemia: inhibition of FoxO1-dependent expression of key autophagy genes by insulin. J Biol Chem (2009) 1.93

Casein kinase 1alpha governs antigen-receptor-induced NF-kappaB activation and human lymphoma cell survival. Nature (2008) 1.91

A phase I/II trial of hydroxychloroquine in conjunction with radiation therapy and concurrent and adjuvant temozolomide in patients with newly diagnosed glioblastoma multiforme. Autophagy (2014) 1.85

Combined autophagy and proteasome inhibition: a phase 1 trial of hydroxychloroquine and bortezomib in patients with relapsed/refractory myeloma. Autophagy (2014) 1.84

Autophagy and apoptosis: what is the connection? Trends Cell Biol (2011) 1.81

p53-dependent regulation of autophagy protein LC3 supports cancer cell survival under prolonged starvation. Proc Natl Acad Sci U S A (2010) 1.77

Phase I trial of hydroxychloroquine with dose-intense temozolomide in patients with advanced solid tumors and melanoma. Autophagy (2014) 1.77

Involvement of autophagy in oncogenic K-Ras-induced malignant cell transformation. J Biol Chem (2011) 1.74

Combined autophagy and HDAC inhibition: a phase I safety, tolerability, pharmacokinetic, and pharmacodynamic analysis of hydroxychloroquine in combination with the HDAC inhibitor vorinostat in patients with advanced solid tumors. Autophagy (2014) 1.67

Casein kinase 1: Complexity in the family. Int J Biochem Cell Biol (2010) 1.63

Csnk1a1 inhibition has p53-dependent therapeutic efficacy in acute myeloid leukemia. J Exp Med (2014) 1.62

Regulation of p53-MDMX interaction by casein kinase 1 alpha. Mol Cell Biol (2005) 1.41

Regulation of casein kinase I epsilon activity by Wnt signaling. J Biol Chem (2004) 1.40

FOXO transcription factors: key regulators of cellular quality control. Trends Biochem Sci (2014) 1.32

Ras isoform abundance and signalling in human cancer cell lines. Oncogene (2007) 1.30

Phase I clinical trial and pharmacodynamic evaluation of combination hydroxychloroquine and doxorubicin treatment in pet dogs treated for spontaneously occurring lymphoma. Autophagy (2014) 1.29

Autophagy-dependent production of secreted factors facilitates oncogenic RAS-driven invasion. Cancer Discov (2014) 1.28

MiR-155 is a liposarcoma oncogene that targets casein kinase-1α and enhances β-catenin signaling. Cancer Res (2012) 1.24

Regulation of casein kinase I epsilon and casein kinase I delta by an in vivo futile phosphorylation cycle. J Biol Chem (1998) 1.23

CK1alpha plays a central role in mediating MDM2 control of p53 and E2F-1 protein stability. J Biol Chem (2009) 1.19

A comprehensive siRNA screen for kinases that suppress macroautophagy in optimal growth conditions. Autophagy (2011) 1.16

IC261 induces cell cycle arrest and apoptosis of human cancer cells via CK1δ/ɛ and Wnt/β-catenin independent inhibition of mitotic spindle formation. Oncogene (2011) 1.15

Regulation of autophagy and chloroquine sensitivity by oncogenic RAS in vitro is context-dependent. Autophagy (2014) 1.10

Autophagy in oncogenic K-Ras promotes basal extrusion of epithelial cells by degrading S1P. Curr Biol (2013) 0.99

CSNK1α1 mediates malignant plasma cell survival. Leukemia (2014) 0.85

Articles by these authors

Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy (2012) 20.08

Post-translational modifications regulate the ticking of the circadian clock. Nat Rev Mol Cell Biol (2007) 5.24

Caspase 3-mediated stimulation of tumor cell repopulation during cancer radiotherapy. Nat Med (2011) 4.68

Control of mammalian circadian rhythm by CKIepsilon-regulated proteasome-mediated PER2 degradation. Mol Cell Biol (2005) 3.03

Autophagy in cancer: good, bad, or both? Cancer Res (2006) 2.66

The circadian regulatory proteins BMAL1 and cryptochromes are substrates of casein kinase Iepsilon. J Biol Chem (2002) 2.48

PKA, PKC, and the protein phosphatase 2A influence HAND factor function: a mechanism for tissue-specific transcriptional regulation. Mol Cell (2003) 2.16

Role for the PP2A/B56delta phosphatase in regulating 14-3-3 release from Cdc25 to control mitosis. Cell (2006) 2.15

Diphtheria toxin-epidermal growth factor fusion protein DAB389EGF for the treatment of bladder cancer. Clin Cancer Res (2012) 2.14

Casein kinase I phosphorylates and destabilizes the beta-catenin degradation complex. Proc Natl Acad Sci U S A (2002) 2.04

An opposite role for tau in circadian rhythms revealed by mathematical modeling. Proc Natl Acad Sci U S A (2006) 2.02

A comprehensive glossary of autophagy-related molecules and processes (2nd edition). Autophagy (2011) 2.02

Pharmacological inhibition of the Wnt acyltransferase PORCN prevents growth of WNT-driven mammary cancer. Cancer Res (2012) 1.89

Altered Twist1 and Hand2 dimerization is associated with Saethre-Chotzen syndrome and limb abnormalities. Nat Genet (2005) 1.89

Chloroquine sensitizes breast cancer cells to chemotherapy independent of autophagy. Autophagy (2012) 1.86

Autophagy and apoptosis: what is the connection? Trends Cell Biol (2011) 1.81

A conserved docking motif for CK1 binding controls the nuclear localization of NFAT1. Mol Cell Biol (2004) 1.78

Inhibition of Mer and Axl receptor tyrosine kinases in astrocytoma cells leads to increased apoptosis and improved chemosensitivity. Mol Cancer Ther (2010) 1.69

Casein kinase 1: Complexity in the family. Int J Biochem Cell Biol (2010) 1.63

MirSNP, a database of polymorphisms altering miRNA target sites, identifies miRNA-related SNPs in GWAS SNPs and eQTLs. BMC Genomics (2012) 1.61

Six1 overexpression in ovarian carcinoma causes resistance to TRAIL-mediated apoptosis and is associated with poor survival. Cancer Res (2007) 1.60

Autophagy and metastasis: another double-edged sword. Curr Opin Cell Biol (2009) 1.57

Targeting autophagy during cancer therapy to improve clinical outcomes. Pharmacol Ther (2011) 1.55

Protein phosphatase 1 regulates assembly and function of the beta-catenin degradation complex. EMBO J (2007) 1.55

WLS-dependent secretion of WNT3A requires Ser209 acylation and vacuolar acidification. J Cell Sci (2010) 1.54

B56-associated protein phosphatase 2A is required for survival and protects from apoptosis in Drosophila melanogaster. Mol Cell Biol (2002) 1.52

Stroma provides an intestinal stem cell niche in the absence of epithelial Wnts. Development (2014) 1.49

Phosphorylation of FADD at serine 194 by CKIalpha regulates its nonapoptotic activities. Mol Cell (2005) 1.45

Mediation of the DCC apoptotic signal by DIP13 alpha. J Biol Chem (2002) 1.43

Protein serine/threonine phosphatases: life, death, and sleeping. Curr Opin Cell Biol (2005) 1.41

Regulation of casein kinase I epsilon activity by Wnt signaling. J Biol Chem (2004) 1.40

BCL-2 family inhibitors enhance histone deacetylase inhibitor and sorafenib lethality via autophagy and overcome blockade of the extrinsic pathway to facilitate killing. Mol Pharmacol (2009) 1.38

Wnt signaling in development, disease and translational medicine. Curr Drug Targets (2008) 1.36

Autophagy and cancer therapy. Cancer Biol Ther (2011) 1.32

A uniform human Wnt expression library reveals a shared secretory pathway and unique signaling activities. Differentiation (2012) 1.31

Two conserved domains in regulatory B subunits mediate binding to the A subunit of protein phosphatase 2A. Eur J Biochem (2002) 1.28

Autophagy inhibition for chemosensitization and radiosensitization in cancer: do the preclinical data support this therapeutic strategy? J Pharmacol Exp Ther (2013) 1.24

African swine fever virus proteins involved in evading host defence systems. Vet Immunol Immunopathol (2004) 1.24

Control of mitotic exit by PP2A regulation of Cdc25C and Cdk1. Proc Natl Acad Sci U S A (2007) 1.24

A Wnt-CKIvarepsilon-Rap1 pathway regulates gastrulation by modulating SIPA1L1, a Rap GTPase activating protein. Dev Cell (2007) 1.22

Mechanism of regulation of casein kinase I activity by group I metabotropic glutamate receptors. J Biol Chem (2002) 1.21

Selective inactivation of a Fas-associated death domain protein (FADD)-dependent apoptosis and autophagy pathway in immortal epithelial cells. Mol Biol Cell (2005) 1.21

Direct binding of Fas-associated death domain (FADD) to the tumor necrosis factor-related apoptosis-inducing ligand receptor DR5 is regulated by the death effector domain of FADD. J Biol Chem (2004) 1.18

STAT3-mediated autophagy dependence identifies subtypes of breast cancer where autophagy inhibition can be efficacious. Cancer Res (2014) 1.17

Loss of viability during freeze-thaw of intact and adherent human embryonic stem cells with conventional slow-cooling protocols is predominantly due to apoptosis rather than cellular necrosis. J Biomed Sci (2005) 1.17

Apoptosis by leukemia cell-targeted diphtheria toxin occurs via receptor-independent activation of Fas-associated death domain protein. Clin Cancer Res (2003) 1.16

Inhibition of autophagy impairs tumor cell invasion in an organotypic model. Cell Cycle (2012) 1.14

BUBR1 recruits PP2A via the B56 family of targeting subunits to promote chromosome congression. Biol Open (2013) 1.12

Translational evidence that impaired autophagy contributes to arterial ageing. J Physiol (2012) 1.12

Interstitial diphtheria toxin-epidermal growth factor fusion protein therapy produces regressions of subcutaneous human glioblastoma multiforme tumors in athymic nude mice. Clin Cancer Res (2005) 1.11

Hedgehog signaling alters reliance on EGF receptor signaling and mediates anti-EGFR therapeutic resistance in head and neck cancer. Cancer Res (2013) 1.06

Antiinflammatory effects of genistein, a tyrosine kinase inhibitor, on a guinea pig model of asthma. Am J Respir Crit Care Med (2002) 1.05

Association of KLK3 (PSA) genetic variants with prostate cancer risk and PSA levels. Carcinogenesis (2011) 1.04

Differential expression of the B'beta regulatory subunit of protein phosphatase 2A modulates tyrosine hydroxylase phosphorylation and catecholamine synthesis. J Biol Chem (2006) 1.03

Ablation of TRIP-Br2, a regulator of fat lipolysis, thermogenesis and oxidative metabolism, prevents diet-induced obesity and insulin resistance. Nat Med (2013) 1.02

The insulin-like growth factor I receptor/insulin receptor tyrosine kinase inhibitor PQIP exhibits enhanced antitumor effects in combination with chemotherapy against colorectal cancer models. Clin Cancer Res (2010) 1.02

The C-terminal tails of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and Fas receptors have opposing functions in Fas-associated death domain (FADD) recruitment and can regulate agonist-specific mechanisms of receptor activation. J Biol Chem (2004) 1.02

Precise regulation of porcupine activity is required for physiological Wnt signaling. J Biol Chem (2012) 1.02

The vitamin E analogue α-TEA stimulates tumor autophagy and enhances antigen cross-presentation. Cancer Res (2012) 1.01

Nuclear and cytoplasmic shuttling of TRADD induces apoptosis via different mechanisms. J Cell Biol (2002) 1.00

Alkylation of the tumor suppressor PTEN activates Akt and β-catenin signaling: a mechanism linking inflammation and oxidative stress with cancer. PLoS One (2010) 1.00

Protein phosphatase 1 regulates the stability of the circadian protein PER2. Biochem J (2006) 0.99

Psammaplin A as a general activator of cell-based signaling assays via HDAC inhibition and studies on some bromotyrosine derivatives. Bioorg Med Chem (2008) 0.99

MicroRNAs and target site screening reveals a pre-microRNA-30e variant associated with schizophrenia. Schizophr Res (2010) 0.98

Regulation of HMGB1 release by autophagy. Autophagy (2009) 0.97

Tumor-derived mutations in the TRAIL receptor DR5 inhibit TRAIL signaling through the DR4 receptor by competing for ligand binding. J Biol Chem (2007) 0.96

PORCN moonlights in a Wnt-independent pathway that regulates cancer cell proliferation. PLoS One (2012) 0.96

Regulation of BRCA1 phosphorylation by interaction with protein phosphatase 1alpha. Cancer Res (2002) 0.96

Distinct TRAIL resistance mechanisms can be overcome by proteasome inhibition but not generally by synergizing agents. Cancer Res (2011) 0.96

Negative regulation of LRP6 function by casein kinase I epsilon phosphorylation. J Biol Chem (2006) 0.96

Casein kinase I in the mammalian circadian clock. Methods Enzymol (2005) 0.95

TP53 genomic status regulates sensitivity of gastric cancer cells to the histone methylation inhibitor 3-deazaneplanocin A (DZNep). Clin Cancer Res (2012) 0.95

Autophagy and cell death. Essays Biochem (2013) 0.95

Lactobacillus species is more cytotoxic to human bladder cancer cells than Mycobacterium Bovis (bacillus Calmette-Guerin). J Urol (2002) 0.94

Activation of caspase pathways during iron chelator-mediated apoptosis. J Biol Chem (2002) 0.94

Ablation of dihydroceramide desaturase 1, a therapeutic target for the treatment of metabolic diseases, simultaneously stimulates anabolic and catabolic signaling. Mol Cell Biol (2013) 0.93

Depression in college: depressive symptoms and personality factors in Beijing and Hong Kong college freshmen. Compr Psychiatry (2008) 0.93

Role of IGF system of mitogens in the induction of fibroblast proliferation by keloid-derived keratinocytes in vitro. Am J Physiol Cell Physiol (2002) 0.93

Acute myeloid leukemia-targeted toxin activates both apoptotic and necroptotic death mechanisms. PLoS One (2008) 0.92

Converging evidence implicates the abnormal microRNA system in schizophrenia. Schizophr Bull (2014) 0.91

Site-specific casein kinase 1epsilon-dependent phosphorylation of Dishevelled modulates beta-catenin signaling. FEBS J (2006) 0.91

Lactobacillus rhamnosus GG induces tumor regression in mice bearing orthotopic bladder tumors. Cancer Sci (2009) 0.91

Phosphatase WIP1 regulates adult neurogenesis and WNT signaling during aging. J Clin Invest (2014) 0.89

Interleukin-1α mediates the antiproliferative effects of 1,25-dihydroxyvitamin D3 in prostate progenitor/stem cells. Cancer Res (2011) 0.89

Caspase- and serine protease-dependent apoptosis by the death domain of FADD in normal epithelial cells. Mol Biol Cell (2003) 0.89

Regulation of the Pro-apoptotic scaffolding protein POSH by Akt. J Biol Chem (2007) 0.88

Diphtheria toxin fused to variant interleukin-3 provides enhanced binding to the interleukin-3 receptor and more potent leukemia cell cytotoxicity. Exp Hematol (2004) 0.87

GST-pi expression correlates with oxidative stress and apoptosis in breast cancer. Oncol Rep (2004) 0.87

Chronic exposure to U18666A induces apoptosis in cultured murine cortical neurons. Biochem Biophys Res Commun (2004) 0.87

Regulation of Fas-associated death domain interactions by the death effector domain identified by a modified reverse two-hybrid screen. J Biol Chem (2002) 0.87

Expression of FGFR1 is an independent prognostic factor in triple-negative breast cancer. Breast Cancer Res Treat (2015) 0.86

A phase II study of neoadjuvant chemoradiotherapy with oxaliplatin and capecitabine for rectal cancer. Cancer Lett (2011) 0.86

The nucleophosmin-anaplastic lymphoma kinase fusion protein induces c-Myc expression in pediatric anaplastic large cell lymphomas. Am J Pathol (2002) 0.86

Cytokeratins in papillary lesions of the breast: is there a role in distinguishing intraductal papilloma from papillary ductal carcinoma in situ? Am J Surg Pathol (2005) 0.86

Updating the Wnt pathways. Biosci Rep (2014) 0.86

Disease-associated casein kinase I delta mutation may promote adenomatous polyps formation via a Wnt/beta-catenin independent mechanism. Int J Cancer (2007) 0.85

Replication study confirms link between TSPAN18 mutation and schizophrenia in Han Chinese. PLoS One (2013) 0.85

Live and lyophilized Lactobacillus species elicit differential immunomodulatory effects on immune cells. FEMS Microbiol Lett (2009) 0.84

Lack of association between MPC2 variants and schizophrenia in a replication study of Han Chinese. Neurosci Lett (2013) 0.84